While bioethicists may enjoy the most thorough appreciation ofboth the promise and perils of new biotechnologies, internationalcorporations are in fact the entities generating these technologiesand determining their application. An industry insider versed inthe language of bioethics, Rahul Dhanda offers in GuidingIcarus: Merging Bioethics with Corporate Interests aRosetta stone to these two camps, explaining why each needs theother, why their disparate concerns often cohere, and why anethical business is likely a successful one.
The author develops a dialogue between bioethics and corporateinterests by examining case studies of several hot-button issues,including:
- Genetically modified foods
- DNA data banking
- Personalized medicine
- Stem cell research
In each instance he provides a treatment of the particularscience under consideration, a list of the benefits of thetechnology, a description of the ethical issues involved, anaccount of past industry response, and recommendations for futureaction. Given the expansive nature of biotechnology, ramificationsin the pharmaceutical and agricultural industries are covered indepth as well. The book also features a Foreword by world-renownedbioethicist and biotechnology CEO Philip R. Reilly as well as astep-by-step discussion of the components of business andbioethical issues.
Written for a general audience, Guiding Icarus will beparticularly useful to biotechnologists, regulatory affairsmanagers, and corporate officers of biotechnology firms, as well asbioethicists in the academic community. Dhanda's peerless textprovides a unique tool for understanding and addressing the ethicaldilemmas confronting society in the 21st century.
|Product dimensions:||6.00(w) x 8.90(h) x 0.60(d)|
About the Author
Table of ContentsForeword.Preface.Acknowledgments.Introduction.Genetically Modified Foods.DNA Data Banking.Personalized Medicine.Stem Cells.Conclusion.Glossary.Suggested Reading.Index.
What People are Saying About This
"Guiding Icarus [...] is timely and well written. I particularlyenjoyed reading the chapters on Personalized Medicine and StemCells. People new to these "hot" topics will find [the]descriptions very informative." --Milo Gibaldi, Department ofPharmaceutics, University of Washington School of Pharmacy
A Featured Book Recommendation with a link to buy the book onHarvard Business School's website: "...lays out a blueprint forexecutives...focusing on four subjects..." --HBS (Harvard BusinessSchool) Working Knowledge, July 2002